Market Cap (In CNY)
3.06 Billion
Revenue (In CNY)
196.83 Million
Net Income (In CNY)
-151.49 Million
Avg. Volume
13.14 Million
- Currency
- CNY
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 2.94-9.54
- PE
- -28.33
- EPS
- -0.15
- Beta Value
- 0.254
- ISIN
- CNE1000022R8
- CUSIP
- -
- CIK
- -
- Shares
- 721245000.0
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Ms. Ling Ping Tao
- Employee Count
- -
- Website
- https://www.lingkang.com.cn
- Ipo Date
- 2015-05-28
- Details
- Lionco Pharmaceutical Group Co., Ltd., together with its subsidiaries, researches, develops, produces, and sells pharmaceuticals in China. The company offers nutrition, antimicrobial, antiviral, digestion, cardiovascular, detoxification, anti-tumor, and other products. It also operates research institutes that specialize in the research of chemical drugs, natural medicines, and biological drugs. Lionco Pharmaceutical Group Co., Ltd. was founded in 2003 and is based in Shannan, China.
More Stocks
-
DOMODomo, Inc.
DOMO
-
RN70
-
4644Imagineer Co.,Ltd.
4644
-
DAE
-
USB-PRU.S. Bancorp
USB-PR
-
002457
-
WLDBFWildBrain Ltd.
WLDBF
-
603004